News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Min-Han Tan: LIQUIK is the world’s first prospective multi-center head-to-head liquid biopsy study
milkeninstitute.org
Nov 3, 2023, 19:24

Min-Han Tan: LIQUIK is the world’s first prospective multi-center head-to-head liquid biopsy study

Quoting Min-Han Tan, CEO and Medical Director at Lucence Health, on LinkedIn:

”LIQUIK is the world’s first prospective multi-center head-to-head liquid biopsy study (NCT04703153).

A 3-way comparison was conducted between tissue sequencing, an FDA-approved ctDNA liquid biopsy test and Liquid Hallmark, an amplicon-based test, for the detection of 9 guideline-recommended biomarkers in lung cancer.

Interim results for the first 120 patients were reported at the IASLC World Conference on Lung Cancer (WCLC) (poster attached here).

So much appreciation to Richa Dawar from University of Miami who presented this work, and the study authors for the efforts!”

Min-Han Tan: LIQUIK is the world's first prospective multi-center head-to-head liquid biopsy study

Source: Min-Han Tan/LinkedIn

cancer liquid biopsy LIQUIK Min-Han Tan OncoDaily Oncology Richa Dawar University of Miami World Conference on Lung Cancer
Special Coverage
Blog
Jan 20, 2025, 14:46
Gregg Margolis: Three things to read about health policy this week
Blog
Jan 20, 2025, 14:43
Afreen Shariff: Excellent to connect with fellow board members and now friends at the ACCC
Dialogues
Jan 20, 2025, 14:32
The Current Situation with Colorectal Cancer in Kazakhstan
Science
Jan 20, 2025, 14:17
Hung Trinh: Bispecific Antibodies in Cancer Therapy
Insight
Jan 20, 2025, 14:16
Amy Moore: Ensuring that all patients benefit from recent scientific advances in lung cancer
Blog
Jan 20, 2025, 14:04
Emily Drake: I finally joined Bluesky
Insight
Jan 20, 2025, 14:03
Richard Sullivan: Radiotherapy is the core modality in cancer care with proven ROI
Blog
Jan 20, 2025, 13:56
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer
Blog
Jan 20, 2025, 13:56
Luis Felipe Tapias: It has been 4 years since I started as a Thoracic Surgeon at Mayo Clinic
Opinion
Jan 20, 2025, 13:56
Amol Akhade: Do oncologists from LMICs and HICs treat and read about only certain solid tumors or all of them?
Blog
Jan 20, 2025, 13:55
Mayo Clinic Transplant completed over 2,000 solid organ transplants in 2024
Blog
Jan 20, 2025, 13:55
Paolo Tarantino: 10 facts to know on Dato-DXd